Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Penta Valent Tbk. (PEVE) Price & Performance

Indofarma Tbk.Trade
Penta Valent Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Penta Valent Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Penta Valent Tbk. trades at Rp308 (market cap 547.34B, 764.8K 24h volume). The key difference: Penta Valent Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFPEVE
Market Cap
390.51B547.34B
Volume
764.8K
Lot
7.65K
Turnover
234.84M
Average Price
307.07
Value
234.84M
Indicative Equilibrium Price
308
Indicative Equilibrium Volume
352

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
PEVE
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Penta Valent Tbk.

PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.

Read more on PEVE